Navigation Links
CVS/pharmacy to Remove OTC Infant Cough & Cold Products from Its Stores as Part of CHPA's Voluntary Withdrawal
Date:10/11/2007

WOONSOCKET, R.I., Oct. 11 /PRNewswire/ -- CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), announced today that it is removing oral over-the-counter (OTC) infant cough & cold medicines from its stores as part of the Consumer Healthcare Products Association's (CHPA) voluntary withdrawal of these products.

Over-the-counter children's cough and cold medicine is safe and effective when used as directed. CHPA has announced the voluntary withdrawal of oral OTC infant cough and cold products due to rare instances of misuse leading to overdose, particularly involving infants under the age of two.

Effective immediately, CVS/pharmacy will remove from its stores all products subject to this voluntary withdrawal, as well as any CVS/pharmacy Brand equivalents. A block is being placed in our point-of-sale system to prevent sales of these items and all affected product is being removed from our store shelves. Customers who purchased any of these products at CVS/pharmacy may return them for a full refund.

Customers should discuss with their CVS pharmacist or their children's pediatrician alternative methods that are available for treating cough and cold symptoms in children under the age of two.

"The health and safety of our customers and their children is our highest priority," said Mike Bloom, Senior Vice President of Merchandising at CVS/pharmacy. "We support this voluntary action because CHPA is dedicated to ensuring the safety of healthcare products on the market and their members are some of our most trusted suppliers."

The voluntary product withdrawal does not affect infant and children's pain relievers, single-ingredient analgesics and nasal spray, drops or rubs for infants, or cough and cold medicines for children ages two and above.

For a complete list of products being voluntarily withdrawn or for more information about the withdrawal, please visit http://www.otcsafety.org .

About CVS/pharmacy

CVS/pharmacy, the retail division of CVS Caremark Corporation, is America's largest retail pharmacy with approximately 6,200 retail locations. CVS/pharmacy is committed to serving the healthcare needs of all customers by being the easiest pharmacy for customers to use, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at http://www.cvs.com/pressroom, as well as http://investor.cvs.com.


'/>"/>
SOURCE CVS/pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indonesian boy with huge neck tumor was surgically removed
2. Virus Helps Remove Brain Cancer
3. Surgery to remove tumors in the spine
4. No special Detergents Required To Remove Lead-Laden Dust
5. Products Removed From Shelves Due To Aflatoxin
6. Thai Doctors Removed 421 Kidney Stones From A Single Person
7. Healthy Kidney Removed From Patient, Second Surgery Needed
8. 10-Kilo Tumor Removed From Cancer Patient
9. Oral Medicine Found To Remove Excess Iron in the Body
10. Arrow Embedded In Tribal’s Chest For Two Weeks Surgically Remove
11. Minute Spring Removed From Boys Throat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... Smiles by ... Shopping Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled ... services under one roof. Smiles by Seese serves patients of all ages with excellence ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... brings its educational assistance management solution to the exhibit floor for the ... Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 healthcare industry ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica ... focusing on all facets of clinical trial planning and management. Pharmica discussed the ... and more. In addition, attendees stopping by Pharmica’s booth were able to demo ...
(Date:2/17/2017)... ... 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from around the ... - 23 in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive ... Beaver Creek, hosting over 60 faculty members and addressing unmet needs of the NET ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... YORK , Feb. 17, 2017  BioDigital, ... today the partnership of their 3D body mapping ... healthcare IT.  The new integration will be used ... an interactive model of the human body. BioDigital ... saves clinicians time, while also increasing the precision ...
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
(Date:2/16/2017)... , Feb. 16, 2017 Research ... Markets for Emerging Medical Device Technologies" report to their ... ... valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, ... been in use over the last two to three decades ...
Breaking Medicine Technology: